{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:17:39Z","timestamp":1792113459933,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.fjurol.2024.102754","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T16:09:20Z","timestamp":1727971760000},"page":"102754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of ketamine cystitis: National guidelines from the French Association of Urology (CUROPF\/CTMH)"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8712-5752","authenticated-orcid":false,"given":"Alice","family":"Bourillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Nicolas","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Herve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Pangui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Thuillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7700-5622","authenticated-orcid":false,"given":"Steeve","family":"Doizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souhil","family":"Lebdai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fjurol.2024.102754_bib0285","unstructured":"Other drugs\u00a0\u2013\u00a0the current situation in Europe (European Drug Report 2024). www.euda.europa.eu [Internet]. [cit\u00e9 23 juill 2024. Disponible sur\u00a0: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024\/other-drugs_en]."},{"key":"10.1016\/j.fjurol.2024.102754_bib0290","series-title":"Substances psychoactives, usagers et march\u00e9s\u00a0: tendances en 2022","author":"G\u00e9rome","year":"2023"},{"issue":"11","key":"10.1016\/j.fjurol.2024.102754_bib0295","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2105\/AJPH.2021.306486","article-title":"Trends in ketamine use, exposures, and seizures in the United States up to 2019","volume":"111","author":"Palamar","year":"2021","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.fjurol.2024.102754_bib0300","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","article-title":"Ketamine-associated ulcerative cystitis: a new clinical entity","volume":"69","author":"Shahani","year":"2007","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102754_bib0305","first-page":"466","article-title":"Systematic review and meta-analysis of ketamine-associated uropathy","volume":"28","author":"Chan","year":"2022","journal-title":"Hong Kong Med J Xianggang Yi Xue Za Zhi"},{"key":"10.1016\/j.fjurol.2024.102754_bib0310","unstructured":"Urofrance. Recommandations du comit\u00e9 de canc\u00e9rologie de l\u2019Association fran\u00e7aise d\u2019urologie\u00a0\u2013\u00a0actualisation 2022\u20132024\u00a0: tumeurs de la voie excr\u00e9trice urinaire sup\u00e9rieure (TVES)\u00a0\u2013\u00a0Urofrance [Internet]. [cit\u00e9 13 sept 2024. Disponible sur\u00a0: https:\/\/www.urofrance.org\/recommandation\/recommandations-du-comite-de-cancerologie-de-lassociation-francaise-durologie-actualisation-2022-2024-tumeurs-de-la-voie-excretrice-urinaire-superieure-t\/?date=&themes=&search=]."},{"key":"10.1016\/j.fjurol.2024.102754_bib0315","unstructured":"OCEBM Levels of Evidence [Internet]. [cit\u00e9 20 juill 2024. Disponible sur\u00a0: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence]."},{"issue":"1","key":"10.1016\/j.fjurol.2024.102754_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharma.2021.04.005","article-title":"Histoire de la k\u00e9tamine\u00a0: une mol\u00e9cule ancienne qui a toujours la cote","volume":"80","author":"Le Dar\u00e9","year":"2022","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.fjurol.2024.102754_bib0325","unstructured":"PubChem. Ketamine [Internet]. [cit\u00e9 8 mai 2024. Disponible sur\u00a0: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/3821]."},{"key":"10.1016\/j.fjurol.2024.102754_bib0330","series-title":"StatPearls [Internet]","article-title":"Ketamine toxicity","author":"Orhurhu","year":"2024"},{"key":"10.1016\/j.fjurol.2024.102754_bib0335","unstructured":"Ketalar: US food and drug administration, Center\u2026 - Google Scholar [Internet]. [cit\u00e9 8 mai 2024. Disponible sur\u00a0: https:\/\/scholar.google.com\/scholar_lookup?title=Label%20and%20Approval%20History&publication_year=1970&author=Ketalar&author=U.S.%20food%20and%20drug%20administration%20center%20for%20drug%20evaluation%20and%20research]."},{"key":"10.1016\/j.fjurol.2024.102754_bib0340","series-title":"Mise au point sur l\u2019utilisation de la K\u00e9tamine\u00a0\u2013\u00a0La SFAR [Internet]","author":"Admin","year":"2018"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102754_bib0345","first-page":"CD004603","article-title":"Perioperative ketamine for acute postoperative pain","author":"Bell","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.fjurol.2024.102754_bib0350","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy","volume":"55","author":"Peltoniemi","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102754_bib0355","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Witkin JM, \u00e9diteur","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.fjurol.2024.102754_bib0360","series-title":"Ketamine panpharma 50\u00a0mg\/mL","author":"Capucine","year":"2023"},{"key":"10.1016\/j.fjurol.2024.102754_bib0365","unstructured":"CT-18432_SPRAVATO_PIC_INS_AvisDef_CT18432_EPI673.pdf [Internet]. [cit\u00e9 11 mai 2024. Disponible sur: https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-18432_SPRAVATO_PIC_INS_AvisDef_CT18432_EPI673.pdf]."},{"key":"10.1016\/j.fjurol.2024.102754_bib0370","unstructured":"ANSM [Internet]. [cit\u00e9 11 mai 2024. Actualit\u00e9\u00a0\u2013\u00a0L\u2019ANSM rappelle le bon usage de la k\u00e9tamine. Disponible sur\u00a0: https:\/\/ansm.sante.fr\/actualites\/lansm-rappelle-le-bon-usage-de-la-ketamine]."},{"issue":"1","key":"10.1016\/j.fjurol.2024.102754_bib0375","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1038\/s41467-020-18167-4","article-title":"Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.fjurol.2024.102754_bib0380","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/bju.12256","article-title":"Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls","volume":"112","author":"Lee","year":"2013","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.fjurol.2024.102754_bib0385","doi-asserted-by":"crossref","first-page":"F318","DOI":"10.1152\/ajprenal.00607.2014","article-title":"Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum","volume":"309","author":"Liu","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.fjurol.2024.102754_bib0390","doi-asserted-by":"crossref","first-page":"F961","DOI":"10.1152\/ajprenal.00686.2016","article-title":"Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-\u03b21","volume":"313","author":"Wang","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102754_bib0395","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.juro.2011.04.102","article-title":"Involvement of purinergic neurotransmission in ketamine induced bladder dysfunction","volume":"186","author":"Meng","year":"2011","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102754_bib0400","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/nau.23900","article-title":"GAG replenishment therapy for bladder pain syndrome\/interstitial cystitis","volume":"38","author":"Wyndaele","year":"2019","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102754_bib0405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/tcmj.tcmj_94_23","article-title":"Pathophysiology, clinical presentation, and management of ketamine-induced cystitis","volume":"35","author":"Jhang","year":"2023","journal-title":"Tzu Chi Med J"},{"key":"10.1016\/j.fjurol.2024.102754_bib0410","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerg Health Threats J"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102754_bib0415","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/luts.12178","article-title":"Risk factors of lower urinary tract syndrome among ketamine users","volume":"10","author":"Chen","year":"2018","journal-title":"Low Urin Tract Symptoms"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102754_bib0420","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/s41598-019-43746-x","article-title":"A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102754_bib0425","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.urology.2015.05.003","article-title":"Clinical outcome of a prospective case series of patients with ketamine cystitis who underwent standardized treatment protocol","volume":"86","author":"Yee","year":"2015","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102754_bib0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1757-5672.2011.00101.x","article-title":"Ketamine-induced uropathy: a new clinical entity causing lower urinary tract symptoms","volume":"4","author":"Chang","year":"2012","journal-title":"Low Urin Tract Symptoms"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102754_bib0435","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1464-410X.2011.10780.x","article-title":"Sexual dysfunction in women with ketamine cystitis: a case-control study","volume":"110","author":"Jang","year":"2012","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.fjurol.2024.102754_bib0440","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/bju.12675","article-title":"One-stop clinic for ketamine-associated uropathy: report on service delivery model, patients\u2019 characteristics and non-invasive investigations at baseline by a cross-sectional study in a prospective cohort of 318 teenagers and young adults","volume":"114","author":"Tam","year":"2014","journal-title":"BJU Int"},{"issue":"1062","key":"10.1016\/j.fjurol.2024.102754_bib0445","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/postgradmedj-2013-131776","article-title":"Evaluation of the extent of ketamine-induced uropathy: the role of CT urography","volume":"90","author":"Huang","year":"2014","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102754_bib0450","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000338098","article-title":"Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity","volume":"89","author":"Lai","year":"2012","journal-title":"Urol Int"},{"issue":"12","key":"10.1016\/j.fjurol.2024.102754_bib0455","doi-asserted-by":"crossref","first-page":"660","DOI":"10.11622\/smedj.2015185","article-title":"The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore","volume":"56","author":"Yek","year":"2015","journal-title":"Singapore Med J"},{"issue":"6","key":"10.1016\/j.fjurol.2024.102754_bib0460","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2559.2009.03437.x","article-title":"Ketamine cystitis as a mimic of carcinoma in situ","volume":"55","author":"Oxley","year":"2009","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102754_bib0465","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/s41598-019-43746-x","article-title":"A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.fjurol.2024.102754_bib0470","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/j.1464-410X.2012.11028.x","article-title":"The prevalence and natural history of urinary symptoms among recreational ketamine users","volume":"110","author":"Winstock","year":"2012","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102754_bib0475","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/nau.25148","article-title":"Current approaches for the treatment of ketamine-induced cystitis","volume":"42","author":"Zhou","year":"2023","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"10.1016\/j.fjurol.2024.102754_bib0480","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1464-410X.2008.07920.x","article-title":"The destruction of the lower urinary tract by ketamine abuse: a new syndrome?","volume":"102","author":"Chu","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102754_bib0485","unstructured":"CT-16342_ELMIRON_PIC_INS_Avis3_CT16342.pdf [Internet]. [cit\u00e9 17 mai 2024. Disponible sur\u00a0: https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-16342_ELMIRON_PIC_INS_Avis3_CT16342.pdf]."},{"issue":"6","key":"10.1016\/j.fjurol.2024.102754_bib0490","first-page":"4","article-title":"Review of intravesical therapies for bladder pain syndrome\/interstitial cystitis","volume":"4","author":"Cvach","year":"2015","journal-title":"Transl Androl Urol"},{"issue":"5","key":"10.1016\/j.fjurol.2024.102754_bib0495","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s11255-013-0501-4","article-title":"Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures","volume":"45","author":"Ng","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.fjurol.2024.102754_bib0500","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0300060517693956","article-title":"Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention","volume":"45","author":"Zeng","year":"2017","journal-title":"J Int Med Res"},{"issue":"11","key":"10.1016\/j.fjurol.2024.102754_bib0505","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520973100","article-title":"Comparison of intravesical instillation of hyaluronic acid with intradetrusor botulinum toxin A injection or cystoscopic hydrodistention for ketamine-associated cystitis","volume":"48","author":"Li","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.fjurol.2024.102754_bib0510","article-title":"Treatment of overative bladder with a peritrigonal injection paradigm of OnabotulinumtoxinA is Associated with a low incidence of clean intermittent catheterization","author":"MacDiarmid","year":"2019","journal-title":"Cont Elsevier [Internet]"},{"issue":"28","key":"10.1016\/j.fjurol.2024.102754_bib0515","doi-asserted-by":"crossref","first-page":"e11500","DOI":"10.1097\/MD.0000000000011500","article-title":"Complete reversal of the clinical symptoms and image morphology of ketamine cystitis after intravesical hyaluronic acid instillation","volume":"97","author":"Ou","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.fjurol.2024.102754_bib0520","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ajpath.2017.06.004","article-title":"Elucidating mechanisms of bladder repair after hyaluronan instillation in ketamine-induced ulcerative cystitis in animal model","volume":"187","author":"Lee","year":"2017","journal-title":"Am J Pathol"},{"issue":"18","key":"10.1016\/j.fjurol.2024.102754_bib0525","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/bjon.2013.22.Sup13.S4","article-title":"Treatment of ketamine-associated cystitis with chondroitin sulphate","volume":"22","author":"Smart","year":"2013","journal-title":"Br J Nurs"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102754_bib0530","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/tcmj.tcmj_94_23","article-title":"Pathophysiology, clinical presentation, and management of ketamine-induced cystitis","volume":"35","author":"Jhang","year":"2023","journal-title":"Tzu Chi Med J"},{"issue":"8","key":"10.1016\/j.fjurol.2024.102754_bib0535","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/nau.22477","article-title":"Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain","volume":"33","author":"Chung","year":"2014","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.fjurol.2024.102754_bib0540","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/bju.14094","article-title":"The effects of recreational ketamine cystitis on urinary tract reconstruction\u00a0\u2013\u00a0a surgical challenge","volume":"121","author":"Sihra","year":"2018","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.fjurol.2024.102754_bib0545","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.3390\/ijms23105771","article-title":"Therapeutic effect of platelet-rich plasma improves bladder overactivity in the pathogenesis of ketamine-induced ulcerative cystitis in a rat model","volume":"23","author":"Chueh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.fjurol.2024.102754_bib0550","doi-asserted-by":"crossref","first-page":"30881","DOI":"10.1038\/srep30881","article-title":"Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.fjurol.2024.102754_bib0555","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/nau.24165","article-title":"Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model","volume":"38","author":"Lee","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.fjurol.2024.102754_bib0560","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1038\/s41598-018-24239-9","article-title":"Potential orphan drug therapy of intravesical liposomal Onabotulinumtoxin-A for ketamine-induced cystitis by mucosal protection and anti-inflammation in a rat model","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024002110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024002110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:16:51Z","timestamp":1733141811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393024002110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":56,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2950393024002110"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102754","relation":{},"ISSN":["2950-3930"],"issn-type":[{"value":"2950-3930","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of ketamine cystitis: National guidelines from the French Association of Urology (CUROPF\/CTMH)","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102754"}}